» Articles » PMID: 36317800

Neuroendocrine Signaling in the Skin with a Special Focus on the Epidermal Neuropeptides

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The skin, which is comprised of the epidermis, dermis, and subcutaneous tissue, is the largest organ in the human body and it plays a crucial role in the regulation of the body's homeostasis. These functions are regulated by local neuroendocrine and immune systems with a plethora of signaling molecules produced by resident and immune cells. In addition, neurotransmitters, endocrine factors, neuropeptides, and cytokines released from nerve endings play a central role in the skin's responses to stress. These molecules act on the corresponding receptors in an intra-, juxta-, para-, or autocrine fashion. The epidermis as the outer most component of skin forms a barrier directly protecting against environmental stressors. This protection is assured by an intrinsic keratinocyte differentiation program, pigmentary system, and local nervous, immune, endocrine, and microbiome elements. These constituents communicate cross-functionally among themselves and with corresponding systems in the dermis and hypodermis to secure the basic epidermal functions to maintain local (skin) and global (systemic) homeostasis. The neurohormonal mediators and cytokines used in these communications regulate physiological skin functions separately or in concert. Disturbances in the functions in these systems lead to cutaneous pathology that includes inflammatory (i.e., psoriasis, allergic, or atopic dermatitis, etc.) and keratinocytic hyperproliferative disorders (i.e., seborrheic and solar keratoses), dysfunction of adnexal structure (i.e., hair follicles, eccrine, and sebaceous glands), hypersensitivity reactions, pigmentary disorders (vitiligo, melasma, and hypo- or hyperpigmentary responses), premature aging, and malignancies (melanoma and nonmelanoma skin cancers). These cellular, molecular, and neural components preserve skin integrity and protect against skin pathologies and can act as "messengers of the skin" to the central organs, all to preserve organismal survival.

Citing Articles

Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea.

Aedo G, Chahuan M, Gatica E, Herrera I, Parada L, Seguel A Int J Mol Sci. 2025; 26(5).

PMID: 40076987 PMC: 11901027. DOI: 10.3390/ijms26052366.


Impact of Minimally Manipulated Cell Therapy on Immune Responses in Radiation-Induced Skin Wound Healing.

Shestakova V, Smirnova E, Atiakshin D, Kisel A, Koryakin S, Litun E Int J Mol Sci. 2025; 26(5).

PMID: 40076619 PMC: 11900442. DOI: 10.3390/ijms26051994.


Nicotinamide: A Multifaceted Molecule in Skin Health and Beyond.

Camillo L, Zavattaro E, Savoia P Medicina (Kaunas). 2025; 61(2).

PMID: 40005371 PMC: 11857428. DOI: 10.3390/medicina61020254.


Recombinant human collagen XVII protects skin basement membrane integrity by inhibiting the MAPK and Wnt signaling pathways.

Wang J, Lin S, Wei Y, Ye Z Mol Med Rep. 2025; 31(4).

PMID: 39981899 PMC: 11868773. DOI: 10.3892/mmr.2025.13465.


Melanin and Neurotransmitter Signalling Genes Are Differentially Co-Expressed in Growing Feathers of White and Rufous Barn Owls.

Ducrest A, San-Jose L, Neuenschwander S, Schmid-Siegert E, Simon C, Pagni M Pigment Cell Melanoma Res. 2025; 38(2):e70001.

PMID: 39910963 PMC: 11799826. DOI: 10.1111/pcmr.70001.


References
1.
Peters E, Tobin D, Seidah N, Schallreuter K . Pro-opiomelanocortin-related peptides, prohormone convertases 1 and 2 and the regulatory peptide 7B2 are present in melanosomes of human melanocytes. J Invest Dermatol. 2000; 114(3):430-7. DOI: 10.1046/j.1523-1747.2000.00913.x. View

2.
WOOD L, Jackson S, Elias P, Grunfeld C, Feingold K . Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992; 90(2):482-7. PMC: 443124. DOI: 10.1172/JCI115884. View

3.
Nagahama M, Funasaka Y, Ohashi A, Chakraborty A, Ueda M, Ichihashi M . Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Br J Dermatol. 1998; 138(6):981-5. DOI: 10.1046/j.1365-2133.1998.02263.x. View

4.
Slominski A, Tobin D, Shibahara S, Wortsman J . Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004; 84(4):1155-228. DOI: 10.1152/physrev.00044.2003. View

5.
Inoue T, Miki Y, Kakuo S, Hachiya A, Kitahara T, Aiba S . Expression of steroidogenic enzymes in human sebaceous glands. J Endocrinol. 2014; 222(3):301-12. DOI: 10.1530/JOE-14-0323. View